MEDIUM
CVE-2006-4255
NVD-CWE-OtherPublished: August 21, 2006· Updated: Jun 16, 2026
4.3
CVSS v3.1
Official Description
Cross-site scripting (XSS) vulnerability in horde/imp/search.php in Horde IMP H3 before 4.1.3 allows remote attackers to include arbitrary web script or HTML via multiple unspecified vectors related to folder names, as injected into the vfolder_label form field in the IMP search screen.
Technical Analysis
CVE-2006-4255 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
Exploitation requires some privileges, which limits the exposure to scenarios where an attacker has already gained initial access.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorNetwork
Attack ComplexityM
Privileges Req.
User Interaction
Scope
Impact
ConfidentialityNone
IntegrityP
AvailabilityNone
AV:N/AC:M/Au:N/C:N/I:P/A:N
Affected Vendors & Products
horde2 product(s)
hordeimp
Source: NVD CPE · 38 total CPE entries
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
Official Patches & Advisories
All References (18)
→
http://secunia.com/advisories/21533Vendor Advisory
→
http://secunia.com/advisories/21533Vendor Advisory
Quick Facts
CVE IDCVE-2006-4255
CVSS Score4.3 / 10
SeverityMEDIUM
WeaknessNVD-CWE-Other
CISA KEVNo
Affected1 vendor(s)
PublishedAug 21, 2006
Related CVEs (NVD-CWE-Other)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2006-4255 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.